Mechanisms of Dosage Compensation

Caenorhabditis elegans

In the nematode C. elegans, the mechanism targets the hermaphrodites (which are XX). The expression levels of genes on both X chromosomes are decreased to $50%$ compared to the levels found in males (X0).

The Lyon Hypothesis and the "Counting" Rule

The mechanism of X-inactivation in mammals is explained by the Lyon Hypothesis, proposed by Mary Lyon in 1961. According to this hypothesis, while all X chromosomes are active during the very early stages of embryonic development, dosage compensation occurs later by converting the extra X chromosomes into Barr bodies.

A fundamental rule of this process is that mammalian cells can "count" their X chromosomes. The cell ensures that only one X chromosome remains active, and any additional X chromosomes are converted into Barr bodies. Mathematically, the number of Barr bodies is always:

$$\text{Number of Barr bodies} = N - 1$$

where $N$ is the total number of X chromosomes.

Exam Tip: If you are asked to determine the number of Barr bodies for a specific genotype, always identify the total number of X chromosomes ($N$) and subtract 1. For example, in Klinefelter syndrome (XXY), $N=2$, so there is $2-1=1$ Barr body.

Clinical Implications: Aneuploidy

Errors in chromosome segregation, known as nondisjunction, can lead to abnormal sex chromosome compositions (aneuploidy):

• Turner syndrome (XO): Individuals are typically short and have female external genitalia but underdeveloped ovaries. Because they have only one X, they have 0 Barr bodies.
• Klinefelter syndrome (XXY): Individuals are typically tall with male genitalia but rudimentary testes. Because they have two X chromosomes, they have 1 Barr body.
• Triple X syndrome (XXX): These females have 2 Barr bodies.

Molecular Mechanisms and Epigenetics

X-inactivation is a prime example of epigenetic inheritance. This means that while the underlying DNA sequence does not change, chemical modifications to the DNA or histones alter gene expression in a way that is passed down to all future somatic cells during cell division.

The Role of Xist and Tsix

The molecular "switch" for this process is located at the X-inactivation center (Xic). This region contains a critical gene called Xist (X-inactive specific transcript).

The process follows three stages:

1. Initiation: The cell counts the Xic loci and targets one X chromosome for inactivation.
2. Spreading: The Xist gene produces an RNA that "coats" the chosen X chromosome, recruiting proteins that cause the chromosome to compact.
3. Maintenance: The inactive state is chemically locked in through DNA methylation and histone modification, ensuring it persists through cell divisions.

A second gene, Tsix, acts as an antisense regulator to Xist; it binds to Xist RNA and inhibits its function, preventing the chromosome from being silenced.

Escaping Inactivation

It is important to note that X-inactivation is not always $100%$ complete. Some genes, such as those in the pseudoautosomal regions (PARs)—which are shared between the X and Y chromosomes—escape inactivation. In humans, up to a quarter of X-linked genes may escape full inactivation.

---

Summary Table: Dosage Compensation Comparison